CITED2 mutation links congenital heart defects to dysregulation of the cardiac gene VEGF and PITX2C expression

Biochemical and Biophysical Research Communications

Volumn 423, Issue 4, 2012, Pages 895-899

  Li, Qian ^a,b   Pan, Hong ^b   Guan, Lina ^b   Su, Dongmei ^b   Ma, Xu ^a,b,c  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^c WHO Collaborative Center for Research in Human Reproduction   (China)

Author keywords

CITED2; Congenital heart disease; Mutation; PITX2C; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MUTANT PROTEIN; PAIRED LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 2 GAMMA; PROTEIN P300; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP2 GAMMA; TRANSCRIPTION FACTOR CITED2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONGENITAL HEART MALFORMATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MISSENSE MUTATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TRANSCRIPTION INITIATION; WILD TYPE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DEFECTS, CONGENITAL; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MUTATION, MISSENSE; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MAMMALIA;

EID: 84863854081     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.099     Document Type: Article

References (19)

1. Hoffman J.I. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr. Cardiol. 1995, 16(3):103-113.
2. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002, 39(12):1890-1900.
3. Clark K.L., Yutzey K.E., Benson D.W. Transcription factors and congenital heart defects. Annu. Rev. Physiol. 2006, 68:97-121.
4. Bruneau B.G. Transcriptional regulation of vertebrate cardiac morphogenesis. Circ. Res. 2002, 90(5):509-519.
5. Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., Smalls O., Johnson M.C., Watson M.S., Seidman J.G., Seidman C.E., Plowden J., Kugler J.D. Mutations in the cardiac transcription factor nkx2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 1999, 104(11):1567-1573.
6. Basson C.T., Bachinsky D.R., Lin R.C., Levi T., Elkins J.A., Soults J., Grayzel D., Kroumpouzou E., Traill T.A., Leblanc-Straceski J., Renault B., Kucherlapati R., Seidman J.G., Seidman C.E. Mutations in human tbx5 [corrected] cause limb and cardiac malformation in holt-oram syndrome. Nat. Genet. 1997, 15(1):30-35.
7. Leung M.K., Jones T., Michels C.L., Livingston D.M., Bhattacharya S. Molecular cloning and chromosomal localization of the human cited2 gene encoding p35srj/mrg1. Genomics 1999, 61(3):307-313.
8. Dunwoodie S.L., Rodriguez T.A., Beddington R.S. Msg1 and mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis. Mech. Dev. 1998, 72(1-2):27-40.
9. Shiama N. The p300/cbp family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 1997, 7(6):230-236.
10. Bhattacharya S., Michels C.L., Leung M.K., Arany Z.P., Kung A.L., Livingston D.M. Functional role of p35srj, a novel p300/cbp binding protein, during transactivation by hif-1. Genes Dev. 1999, 13(1):64-75.
11. Yin Z., Haynie J., Yang X., Han B., Kiatchoosakun S., Restivo J., Yuan S., Prabhakar N.R., Herrup K., Conlon R.A., Hoit B.D., Watanabe M., Yang Y.C. The essential role of cited2, a negative regulator for hif-1alpha, in heart development and neurulation. Proc. Natl. Acad. Sci. USA 2002, 99(16):10488-10493.
12. Freedman S.J., Sun Z.Y., Kung A.L., France D.S., Wagner G., Eck M.J. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by cited2. Nat. Struct. Biol. 2003, 10(7):504-512.
13. Bamforth S.D., Braganca J., Eloranta J.J., Murdoch J.N., Marques F.I., Kranc K.R., Farza H., Henderson D.J., Hurst H.C., Bhattacharya S. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking cited2, a new tfap2 co-activator. Nat. Genet. 2001, 29(4):469-474.
14. Bamforth S.D., Braganca J., Farthing C.R., Schneider J.E., Broadbent C., Michell A.C., Clarke K., Neubauer S., Norris D., Brown N.A., Anderson R.H., Bhattacharya S. Cited2 controls left-right patterning and heart development through a nodal-pitx2c pathway. Nat. Genet. 2004, 36(11):1189-1196.
15. Weninger W.J., Lopes Floro K., Bennett M.B., Withington S.L., Preis J.I., Barbera J.P., Mohun T.J., Dunwoodie S.L. Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development 2005, 132(6):1337-1348.
16. Barbera J.P., Rodriguez T.A., Greene N.D., Weninger W.J., Simeone A., Copp A.J., Beddington R.S., Dunwoodie S. Folic acid prevents exencephaly in cited2 deficient mice. Hum. Mol. Genet. 2002, 11(3):283-293.
17. Schneider J.E., Bamforth S.D., Farthing C.R., Clarke K., Neubauer S., Bhattacharya S. Rapid identification and 3d reconstruction of complex cardiac malformations in transgenic mouse embryos using fast gradient echo sequence magnetic resonance imaging. J. Mol. Cell Cardiol. 2003, 35(2):217-222.
18. Sperling S., Grimm C.H., Dunkel I., Mebus S., Sperling H.P., Ebner A., Galli R., Lehrach H., Fusch C., Berger F., Hammer S. Identification and functional analysis of cited2 mutations in patients with congenital heart defects. Hum. Mutat. 2005, 26(6):575-582.
19. Yang X.F., Wu X.Y., Li M., Li Y.G., Dai J.T., Bai Y.H., Tian J. Mutation analysis of cited2 in patients with congenital heart disease. Zhonghua Er Ke Za Zhi. 2010, 48(4):293-296.